| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/07/2008 | US20080187537 Using immunodeficient animals to generate cancer cell infiltrating lymphocytes; immunotherapy; tissue targeted therapy |
| 08/07/2008 | US20080187536 Immunological modulation of insulin-like growth factor 1 for cancer prevention/treatment and prolonging longevity |
| 08/07/2008 | US20080187533 Treatment with anti-erbb2 antibodies |
| 08/07/2008 | US20080187513 Treatment of Solid Cancers |
| 08/07/2008 | US20080187511 Ointment for cancer treatment |
| 08/07/2008 | US20080187493 Peptide-Based Compounds |
| 08/07/2008 | US20080187487 Methods for producing multilayered particles, fibers and sprays and methods for administering the same |
| 08/07/2008 | DE202006020459U1 Zubereitung mit marinem Kollagen zur Proteinasehemmung Preparation with marine collagen to Proteinasehemmung |
| 08/07/2008 | DE102007061631A1 Verfahren zur Herstellung von Mycophenolat-Mofetil Process for the preparation of mycophenolate mofetil |
| 08/07/2008 | DE102006053594B4 Verfahren zur Reinigung von Letrozol A process for purifying letrozole |
| 08/07/2008 | CA2702647A1 Thiopyrimidine-based compounds and uses thereof |
| 08/07/2008 | CA2677163A1 Humanized antibodies against cxcr3 |
| 08/07/2008 | CA2677096A1 Kinase inhibitors |
| 08/07/2008 | CA2677007A1 Activin-actriia antagonists and uses for treating or preventing breast cancer |
| 08/07/2008 | CA2676912A1 Multi-functional drug carriers |
| 08/07/2008 | CA2676822A1 2-5a analogs and their methods of use |
| 08/07/2008 | CA2676796A1 Composition for treatment of undifferentiated gastric cancer |
| 08/07/2008 | CA2676665A1 Modulators of mitotic kinases |
| 08/07/2008 | CA2676658A1 Modulators of mitotic kinases |
| 08/07/2008 | CA2676551A1 Compositions and methods of use of phorbol esters |
| 08/07/2008 | CA2676168A1 Pharmaceutical compositions and methods of using temozolomide and multi-targeted kinase inhibitors |
| 08/07/2008 | CA2676163A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibitory activity |
| 08/07/2008 | CA2676160A1 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives |
| 08/07/2008 | CA2675677A1 5,6,7,8-tetrahydropteridine derivatives as hsp90 inhibitors |
| 08/07/2008 | CA2673734A1 Macrolide compound in solid form, process for preparation thereof, and pharmaceutical composition containing the same |
| 08/06/2008 | EP1953243A2 Polynucleotides related to colon cancer |
| 08/06/2008 | EP1953173A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/06/2008 | EP1953170A1 Monosaccharide derivatives as anti-inflammatory agents |
| 08/06/2008 | EP1953161A1 New tricyclic derivatives, method of preparing same and pharmaceutical compositions containing them |
| 08/06/2008 | EP1952826A1 Diagnostic agent and therapeutic agent for disease associated with hepatocyte growth factor receptor |
| 08/06/2008 | EP1952825A1 Nanometer targeted drug for magneto-thermotherapy of malignant tumors |
| 08/06/2008 | EP1952811A1 The use of eriocalyxin b in the manufacture of medicaments for treating leukemia |
| 08/06/2008 | EP1952810A1 Treatment of breast cancer with 4-hydroxytamoxifen |
| 08/06/2008 | EP1952700A1 Method of improving absorption of vitamin E by a pet animal |
| 08/06/2008 | EP1951891A1 Cancer antigen mage-a9 and uses thereof |
| 08/06/2008 | EP1951865A1 Stabilizing formulations for recombinant viruses |
| 08/06/2008 | EP1951759A2 Anti-egfr antibodies |
| 08/06/2008 | EP1951750A2 Modulation of angiogenesis by a-beta peptide fragments |
| 08/06/2008 | EP1951739A1 An improved process for the isolation of arjunic acid from the bark of the tree terminalia arjuna and the use of this compound in the treatment of cancer |
| 08/06/2008 | EP1951730A1 Heteroalkyl linked pyrimidine derivatives |
| 08/06/2008 | EP1951729A1 Oxygen linked pyrimidine derivatives |
| 08/06/2008 | EP1951725A1 N-sulfamoyl-n -benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 08/06/2008 | EP1951724A2 FUSED BICYCLIC mTOR INHIBITORS |
| 08/06/2008 | EP1951716A1 Aminopyrimidines useful as kinase inhibitors |
| 08/06/2008 | EP1951711A1 Indole derivatives as antitumoural compounds |
| 08/06/2008 | EP1951698A1 Iap bir domain binding compounds |
| 08/06/2008 | EP1951697A1 Substituted 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazines |
| 08/06/2008 | EP1951687A1 N-hydroxyamide derivatives and use thereof |
| 08/06/2008 | EP1951686A1 Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof |
| 08/06/2008 | EP1951683A1 Pyrimidine derivatives for the treatment of cancer |
| 08/06/2008 | EP1951679A1 Imidazole compounds that modulate hsp90 activity |
| 08/06/2008 | EP1951674A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 08/06/2008 | EP1951665A1 Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof |
| 08/06/2008 | EP1951653A1 Salicylic acid derivatives |
| 08/06/2008 | EP1951318A1 Inhibition of autophagy genes in cancer chemotherapy |
| 08/06/2008 | EP1951307A2 Combination of a cdk-inhibitor and a hdac-inhibitor |
| 08/06/2008 | EP1951283A1 Pharmaceutical composition for treating or preventing ovarian cancer |
| 08/06/2008 | EP1951274A1 Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer |
| 08/06/2008 | EP1951255A1 Staurosporine derivatives for use in alveolar rhabdomyosarcoma |
| 08/06/2008 | EP1951242A2 Combination therapy for the treatment of cancer |
| 08/06/2008 | EP1951239A2 Fixed ratio drug combination treatments for solid tumors |
| 08/06/2008 | EP1951234A2 Method of inhibiting flt3 kinase |
| 08/06/2008 | EP1951230A2 Methods of treating or preventing cancer using pyridine carboxaldehyde pyridine thiosemicarbazone radiosensitizing agents |
| 08/06/2008 | EP1951222A2 Method of treating breast cancer using 17-aag or 17-ag or a prodrug of either in combination with a her2 inhibitor |
| 08/06/2008 | EP1951221A1 Use of angeloyl-substituted ingenanes in combination with other agents to treat cancer |
| 08/06/2008 | EP1951046A2 Methods to enhance chemotherapy |
| 08/06/2008 | EP1778663A4 (-)-epigallocatechin gallate derivatives for inhibiting proteasome |
| 08/06/2008 | EP1773768A4 Pyrrole derivatives as pharmaceutical agents |
| 08/06/2008 | EP1744789B1 X-ray and/or uv activatable particles, their preparation and their therapeutic or diagnostic uses |
| 08/06/2008 | EP1641455B1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors |
| 08/06/2008 | EP1638943B1 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 08/06/2008 | EP1599258B1 Fumed silica embolic compositions |
| 08/06/2008 | EP1568702A4 Palladium complexes with heterocyclic ligands |
| 08/06/2008 | EP1508047B1 Method for identifying immunoreactive peptides |
| 08/06/2008 | EP1495051B1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 08/06/2008 | EP1485088B1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 08/06/2008 | EP1476149B1 Substituted hydrazones as inhibitors of cyclooxygenase-2 |
| 08/06/2008 | EP1455824B1 Lyophilized preparation containing antibodies to the egf receptor |
| 08/06/2008 | EP1449920B1 Trangenic mice used as model for human pathologies originating from stem cells |
| 08/06/2008 | EP1432714B1 Chemical compounds |
| 08/06/2008 | EP1423383B1 Pyridine substituted furan derivatives as raf kinase inhibitors |
| 08/06/2008 | EP1397382B1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 08/06/2008 | EP1377671B1 Oncolytic adenoviral vectors |
| 08/06/2008 | EP1363875B1 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 08/06/2008 | EP1350521B1 Immunotherapeutic combinations for the treatment of tumors |
| 08/06/2008 | EP1311475B1 Aminocyclohexane derivatives |
| 08/06/2008 | EP1257298B1 Cosmid dna constructs and methods of making and using the same |
| 08/06/2008 | EP1157042B1 Production of tetravalent antibodies |
| 08/06/2008 | EP1108034B1 Attenuated salmonella spi2 mutants as antigen carriers |
| 08/06/2008 | EP1023447B1 Human ribonuclease a with reduced ribonuclease inhibitor affinity |
| 08/06/2008 | EP1015884B1 Methods of identifying molecules that home to angiogenic vasculature in tumors |
| 08/06/2008 | EP0832109B1 Fibroblast growth factor homologous factor-2 and methods of use |
| 08/06/2008 | CN101238133A Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 08/06/2008 | CN101238132A Spirochromanone derivatives as acetyl coenzyme A carboxylase(ACC) inhibitors |
| 08/06/2008 | CN101238118A Salts and polymorphs of a VEGF-R inhibitor |
| 08/06/2008 | CN101238117A Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 08/06/2008 | CN101238116A Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors |
| 08/06/2008 | CN101238106A Fluoro substituted 2-oxo azepan derivatives |
| 08/06/2008 | CN101237867A Novel 4-amino-thieno[3,2-C]pyridine-7-carboxylic acid amides |
| 08/06/2008 | CN101237857A Compositions and methods using microspheres and non-ionic contrast agents |